FADS1 and metabolic syndrome: Disturbances in hepatic FA metabolism are well-documented in patients with MetS, and altered FA profiles and activities of polyunsaturated FA metabolizing desaturases, such as delta-5-desaturase (D5D), have been associated with insulin resistance, diabetes, obesity, and MetS [6, 7].